Yüklüyor......
Gemigliptin: Newer Promising Gliptin for Type 2 Diabetes Mellitus
The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, and studies have revealed certain advantages of gem...
Kaydedildi:
| Yayımlandı: | Indian J Endocrinol Metab |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5729681/ https://ncbi.nlm.nih.gov/pubmed/29285456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijem.IJEM_20_17 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|